Blog
Blog
Blog

Inside Themison:

Inside Themison:

Inside Themison:

Stay Updated with Our Latest News, Articles, and Breakthroughs

Stay Updated with Our Latest News, Articles, and Breakthroughs

Stay Updated with Our Latest News, Articles, and Breakthroughs

ALL CATEGORIES

Latest

ALL CATEGORIES

Latest

February 15, 2024

February 15, 2024

A New Chapter: Themison Secures Antler Investment & Gains Entry to the Innofounder Program from the Innovation Fund Denmark

February 15, 2024

February 15, 2024

A New Chapter: Themison Secures Antler Investment & Gains Entry to the Innofounder Program from the Innovation Fund Denmark

Ready to get started?

Subscribe to
Our Newsletter

Subscribe to
Our Newsletter

Subscribe to
Our Newsletter

Stay Informed, and Stay Ahead of the Curve with Our Exclusive Newsletter

Stay Informed, and Stay Ahead of the Curve with Our Exclusive Newsletter

Stay Informed, and Stay Ahead of the Curve with Our Exclusive Newsletter

Founded in 2023, Themison is a Danish health tech company revolutionizing patient engagement in clinical trials. We are open to collaboration and we welcome inquiries from potential business partners, investors, and talented individuals looking to join our team.

Copenhagen, Denmark

info@themison.com

Privacy Policy

Terms of Service

© 2024 by Themison Aps. All rights reserved.

Founded in 2023, Themison is a Danish health tech company revolutionizing patient engagement in clinical trials. We are open to collaboration and we welcome inquiries from potential business partners, investors, and talented individuals looking to join our team.

Copenhagen, Denmark

info@themison.com

© 2024 by Themison Aps. All rights reserved.

Founded in 2023, Themison is a Danish health tech company revolutionizing patient engagement in clinical trials. We are open to collaboration and we welcome inquiries from potential business partners, investors, and talented individuals looking to join our team.

Copenhagen, Denmark

info@themison.com

© 2024 by Themison Aps. All rights reserved.